ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Pomalidomid-Teva 4 mg, Hartkapseln - 14
69576007 Teva Pharma AG
Pomalidomid-Teva 4 mg, Hartkapseln04.11.2024
  04.11.2024
Pomalidomide (L04AX06) 
WHO-DDD03.11.2029
07.16.40.14
07.16.40. 
A  
No 
IP 
PR  
k.A.PR
  
7680695760071Synthetika
  
Composition
pomalidomidum 4 mg, lactosum monohydricum 200 mg, crospovidonum, povidonum K 30, natrii laurilsulfas, natrii stearylis fumaras, Kapselhülle: E 133, E 171, gelatina, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, E 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.538 mg.
Packungsbestandteile
Capsules 
  
 
Active AgentDose
Pomalidomidum4 mg
BAG: Active AgentDose
Pomalidomidum4 mg
 
Inactive agentsDoseadditional_information
(Nigrum)  
Ammoniae Solutio Concentrata  
Crospovidonum  
E 133 Kapselhülle
E 171 color.
E 172 color.
Gelatina  
Kalii Hydroxidum  
Lacca Drucktinte
Lactose Monohydrate200 mg 
Natrii Laurilsulfas  
Natrii Stearylis Fumaras  
Povidonum K30  
Propylenglycol  
 
Source
Data was imported : 04.12.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home